Changing clinical and pathological features of gastric cancer over time

British Journal of Surgery

Volumn 98, Issue 9, 2011, Pages 1273-1283

  Marrelli, D ^a   Pedrazzani, C ^a   Morgagni, P ^b   De Manzoni, G ^c   Pacelli, F ^d   Coniglio, A ^e   Marchet, A ^f   Saragoni, L ^b   Giacopuzzi, S ^c   Roviello, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b MORGAGNI PIERANTONI HOSPITAL   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

^f UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; EPIDEMIOLOGY; FEMALE; GASTRECTOMY; HUMAN; ITALY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; SEX RATIO; STOMACH TUMOR; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; FEMALE; GASTRECTOMY; HUMANS; ITALY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SEX DISTRIBUTION; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 79960845614     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7528     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. La Vecchia C, Bosetti C, Lucchini F, et al., Cancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol 2010; 21: 1323-1360.
3. Bertuccio P, Chatenoud L, Levi F, Praud D, Ferlay J, Negri E, et al., Recent patterns in gastric cancer: a global overview. Int J Cancer 2009; 125: 666-673.
4. Inghelmann R, Grande E, Francisci S, Verdecchia A, Micheli A, Baili P, et al., Regional estimates of stomach cancer burden in Italy. Tumori 2007; 93: 367-373. (Pubitemid 47403452)
5. Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS,. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev 2009; 18: 1945-1952.
6. Laurén PA, Nevalainen TJ,. Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer 1993; 71: 2926-2933. (Pubitemid 23145518)
7. Kaneko S, Yoshimura T,. Time trend analysis of gastric cancer incidence in Japan by histological types, 1975-1989. Br J Cancer 2001; 84: 400-405. (Pubitemid 32154436)
8. Henson DE, Dittus C, Younes M, Nguyen H, Albores-Saavedra J,. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Arch Pathol Lab Med 2004; 128: 765-770. (Pubitemid 38856886)
9. Sasako M, Sano T, Yamamoto S, Kurokawa Y, Nashimoto A, Kurita A, et al., D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359: 453-462.
10. Lee HJ, Yang HK, Ahn YO,. Gastric cancer in Korea. Gastric Cancer 2002; 5: 177-182.
11. Hundahl SA, Phillips JL, Menck HR,. The National Cancer Data Base Report on poor survival of US gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the 'different disease' hypothesis. Cancer 2000; 88: 921-932. (Pubitemid 30091113)
12. Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A, Roviello F,. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 2005; 241: 247-255.
13. Smith DD, Schwarz RR, Schwarz RE,. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol 2005; 23: 7114-7124.
14. Hansson LE, Sparén P, Nyrén O,. Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg 1999; 230: 162-169. (Pubitemid 30191881)
15. Park CH, Song KY, Kim SN,. Treatment results for gastric cancer surgery: 12 years' experience at a single institute in Korea. Eur J Surg Oncol 2008; 34: 36-41. (Pubitemid 350296760)
16. Fayçal J, Bessaguet C, Nousbaum JB, Cauvin JM, Cholet F, Bideau K, et al., Epidemiology and long term survival of gastric carcinoma in the French district of Finistere between 1984 and 1995. Gastroenterol Clin Biol 2005; 29: 23-32. (Pubitemid 40254645)
17. Crane SJ, Locke GR III, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ,. Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc 2008; 83: 1087-1094.
18. Dassen AE, Lemmens VE, van de Poll-Franse LV, Creemers GJ, Brenninkmeijer SJ, Lips DJ, et al., Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer 2010; 46: 1101-1110.
19. Folli S, Morgagni P, Roviello F, De Manzoni G, Marrelli D, Saragoni L, et al., Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC). Jpn J Clin Oncol 2001; 31: 495-499. (Pubitemid 33039764)
20. Marrelli D, Roviello F, de Manzoni G, Morgagni P, Di Leo A, Saragoni L, et al,; Italian Research Group for Gastric Cancer. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study. World J Surg 2002; 26: 1160-1165. (Pubitemid 36920276)
21. Roviello F, Marrelli D, Morgagni P, de Manzoni G, Di Leo A, Vindigni C, et al., Survival benefit of extended D2 lymphadenectomy in gastric cancer with involvement of second level lymph nodes: a longitudinal multicenter study. Ann Surg Oncol 2002; 9: 894-900. (Pubitemid 35265641)
22. Marchet A, Mocellin S, Ambrosi A, Morgagni P, Garcea D, Marrelli D, et al., The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007; 245: 543-552. (Pubitemid 46555657)
23. Verlato G, Roviello F, Marchet A, Giacopuzzi S, Marrelli D, Nitti D, et al., Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol 2009; 16: 594-602.
24. Baiocchi GL, Tiberio GA, Minicozzi AM, Morgagni P, Marrelli D, Bruno L, et al., A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg 2010; 252: 70-73.
25. Sobin LH, Wittekind C, (eds). TNM Classification of Malignant Tumors (UICC) (6th edn). Wiley-Liss: New York, 2002.
26. Marrelli D, Pedrazzani C, Neri A, Corso G, DeStefano A, Pinto E, et al., Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. Ann Surg Oncol 2007; 14: 25-33. (Pubitemid 44954267)
27. Hess KR,. Graphical methods for assessing violations of the proportional hazards assumption in Cox regression. Stat Med 1995; 14: 1707-1723.
28. Blok P, Craanen ME, Offerhaus GJ, Tytgat GN,. Gastric carcinoma: clinical, pathogenic, and molecular aspects. QJM 1997; 90: 735-749. (Pubitemid 28008946)
29. Pedrazzani C, Corso G, Marrelli D, Roviello F,. E-cadherin and hereditary diffuse gastric cancer. Surgery 2007; 142: 645-657. (Pubitemid 350018845)
30. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ,. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010; 11: 439-449.
31. Maruyama K, Okabayashi K, Kinoshita T,. Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11: 418-425. (Pubitemid 17137100)
32. Yoon SS, Yang HK,. Lymphadenectomy for gastric adenocarcinoma: should west meet east? Oncologist 2009; 14: 871-882.
33. Catalano V, Labianca G, Beretta G, Gatta G, de Braud F, Van Cutsem E,. Gastric cancer. Crit Rev Oncol Hematol 2009; 71: 127-164.
34. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al., Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
35. Yan TD, Black D, Sugarbaker PH, Zhu J, Yonemura Y, Petrou G, et al., A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007; 14: 2702-2713. (Pubitemid 47460649)